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Non-communicable respiratory disease in Malawi: a 
systematic review and meta-analysis
ORIGINAL RESEARCH
Abstract
Background
Non-communicable respiratory diseases are important contributors to morbidity and mortality in sub-Saharan African countries such 
as Malawi. 
Aim
To conduct a systematic review of  the available literature relating to chronic respiratory disease in Malawi. 
Methods
We conducted a systematic protocol-driven literature search of  key scientific databases including Scopus and Medline. Papers were 
independently assessed for eligibility by two authors and included if  they reported objective measures (including self-reported standard 
symptoms) of  chronic respiratory disease and were conducted in Malawi. A meta-analysis of  available estimates was then conducted. 
We re-analysed data from three of  these studies in a secondary data analysis to allow for between-study comparisons. 
Results
Our search identified 393 papers of  which 17 (5 involving children and 12 involving adults) met the inclusion criteria. Wheeze was the 
symptom most frequently reported in children in the community (12.1%), hospital (11.2%) and HIV clinic (8.1%) settings. Cough was 
the symptom most frequently reported by adults in the community (3–18%). Spirometric abnormalities varied substantially between 
studies. For example, in adults, airflow obstruction varied between 2.3% and 20% and low forced vital capacity (FVC)   varied between 
2.7% and 52.8%. 
Conclusion
We identified a high burden of  chronic respiratory symptoms and abnormal spirometry (particularly low FVC) within paediatric and 
adult populations in Malawi. The estimates for country-wide burden related to this disease were limited by the heterogeneity of  the 
methods used to assess symptoms and spirometry. There is an urgent need to develop a better understanding of  the determinants and 
natural history of  non-communicable respiratory disease across the life-course in Malawi. 
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Introduction
Non-communicable diseases (NCDs) kill 41 million people 
globally, accounting for 71% of  deaths worldwide1. More 
than three quarters (32 million) of  these deaths occur in 
low- and middle-income countries (LMICs), including 
LMICs in sub-Saharan Africa, such as Malawi. Health 
policy has historically focussed on communicable rather 
than non-communicable disease in sub-Saharan African 
countries2, although the need to prioritise the prevention 
and control of  NCDs is increasingly recognised, with the 
Malawi National Health Research Agenda highlighting the 
fact that chronic lung disorders are a priority research area 
for the country3-5. Non-communicable respiratory diseases 
are major contributors to NCD mortality with 3.6 million 
attributable deaths globally in 20156. Of  these diseases, 
asthma and chronic obstructive pulmonary disease (COPD) 
are the most common7-10. The International Study of  
Asthma and Allergies in Childhood (ISAAC) estimated the 
prevalence of  asthma using standardised questionnaires in 
105 countries11. In the seven countries from sub-Saharan 
Africa, the prevalence of  asthma varied between 9.1% in 
Ethiopia and 20.3% in South Africa11. The prevalence of  
COPD has been estimated from cross-sectional spirometry-
based studies, including the International Burden of  
Obstructive Lung Disease (BOLD) initiative12.  The highest 
prevalence was seen in Cape Town, South Africa where 
moderate to severe obstruction was present in 19.1% of  
the adult population whilst prevalence in Ile-Ife (Nigeria), 
urban Blantyre (Malawi) and rural Chikwawa (Malawi) were 
7.7%, 3.6% and 8.7%, respectively13-16.  Recently, two further 
studies have reported lower levels of  obstruction in Uganda: 
6.1% and 2% in rural populations, and 1.5% in an urban 
population17,18. 
We conducted a systematic review and pooled analysis of  
the burden of  NCDs and the risk factors associated with 
NCDs in Malawi. This review adopted a broad approach and 
focused on any population, any intervention, any comparison 
technique, any outcome, and any study design. 
Methods
Systematic review
This systematic review is registered with the Centre 
for Reviews and Dissemination (Registration number: 
CRD42018117325). The full protocol is available at http://
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Eligibility criteria
Publications were included if  they described the burden 
of  non-communicable respiratory diseases (including 
COPD, asthma, low forced vital capacity (FVC)/restrictive 
disease and bronchiectasis) in Malawian individuals of  any 
population (any sex or age), involving any intervention and 
outcomes linked to non-communicable respiratory disease. 
We included any form of  study design, including  studies 
that defined non-communicable respiratory diseases using 
symptoms, self-reported diagnosis, doctor diagnosis, and 
spirometry.  
Search strategy 
The databases and grey literature listed in Box 1 were 
searched using the specific search terms and Boolean 
phrases listed in Box 2 and the search strategy set out in Box 
3. Identified papers were then imported into EndNote X7. 
The reference lists of  all selected papers were also reviewed 
to identify any potentially eligible titles. For studies where 
relevant details were not available, authors were invited to 
supply information if  their contact details were available.
Article screening
Following the removal of  duplicates, the titles of  all identified 
papers were independently reviewed for eligibility by two 
authors (HJ & RN). Abstracts of  the selected titles, and 
then the full text of  the selected articles, were independently 
reviewed for eligibility by two authors (HJ & RN), according 
to the selection criteria. Discordant decisions were resolved 
by discussion, with final arbitration by a third author. 
Data extraction
Data were extracted by HJ and RN from the selected 
papers using a data extraction form (which had been pre-
tested). These forms were used to create summary tables 
and narrative syntheses. Data extraction was independently 
checked by ML. We also collated information regarding 
exposure to household air pollution, smoking and previous 
TB, where available. 
Methodological quality assessment
The methodological quality of  the selected studies was 
assessed by HJ using the Newcastle-Ottawa Scale for cohort 
and case-control studies (scored out of  9) and a modified 
version of  the Newcastle-Ottawa Scale for cross-sectional 
studies (scored out of  5) (Table 1).
Statistical analysis
Published estimates of  the prevalence of  symptoms, 
obstruction or low FVC, and mean (standard deviation [SD]) 
and median (interquartile range ([IQR]) carbon monoxide 
(CO), and fine particulate matter (PM2.5) were extracted 
for meta-analysis. We then created Forest plots using the 
estimated proportion and 95% confidence intervals. Meta-
analysis estimates of  overall prevalence were stratified 
by age group (adult, paediatric) and estimated using the 
DerSimonian-Laird random effects model (R package 
metaviz)19. Estimates derived from meta-analysis were only 
calculated for outcomes in which the studies were deemed 
to be adequately homogenous. Estimates of  measures of  
heterogeneity (I2, tau2) and an overall Q-test were generated 
using linear mixed effects models (R package metaphor) and 
reported. Publication bias was evaluated by visual inspection 
of  funnel plots.
Data from three of  the studies included in the meta-analysis 
that had been performed using the same core BOLD 
protocol were re-analysed in order to provide comparable 
estimates: the Adult Lung Health Study (ALHS), the 
Box 1: Databases and Grey Literature
Databases:
• Scopus (including EMBASE)
• MEDLINE (OVID)
• Web of  Science
• Cochrane Central Register of  Controlled Trials 
(CENTRAL)
• CINAHL (OVID)
• SciELO
Grey literature:
• World Health Organization Clinical Trials Registry
• www.clinicaltrials.gov
• European Association for Grey Literature Exploitation 
(EAGLE)
Box 2: Search terms and Boolean phrases used
Outcomes (OR):  “chronic respiratory” OR “non-
communicable lung” OR “chronic obstructive pulmonary 
disease” OR “COPD” OR “asthma” OR “obstructive 
lung” OR “restrictive lung” OR “obstructive respiratory” 
OR “restrictive respiratory” OR “obstructive airway*” 
OR “restrictive airway*” OR “spirometr*” OR “wheeze” 
OR “chronic cough” OR “shortness of  breath” OR 
“breathlessness” OR “chronic sputum”
AND
Location: “Malawi” 
Box 3: Example search strategy for Medline (OVID)
1. “chronic respiratory” .mp,tw.
2. “non-communicable lung” .mp,tw.
3. “chronic obstructive pulmonary disease” .mp,tw.
4. COPD.mp,tw.
5. asthma.mp,tw.
6. “obstructive lung” .mp,tw.
7. “restrictive lung” .mp,tw.
8. “obstructive respiratory” .mp,tw.
9. “restrictive respiratory” .mp,tw.
10. “obstructive airway*”.mp,tw.
11. “restrictive airway*”.mp,tw.
12. spirometr*.mp,tw.
13. wheeze.mp,tw.
14. “chronic cough” .mp,tw.
15. “shortness of  breath.mp,tw.
16. “breathlessness” .mp,tw.
17. “chronic sputum” .mp,tw.
18. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 
OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17
19. Malawi.mp,tw.
20. 18 AND 19
mp is combined search field , tw is title and abstract field
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Blantyre Health Study (BHS), and the Acute Infection of  the 
Respiratory tract Study (AIR Study)15,16,20. This allowed for 
the pooled analysis of  data which had not previously been 
performed (referred to subsequently as the “pooled analysis” 
to distinguish this from the “meta-analysis”). Details of  
the sampling and measurement procedures for these three 
studies have been described previously; consequently,  we 
restricted our description of  these methods to the secondary 
analysis presented here12,13,15,16,20,21.  The prevalence (with SD) 
of  symptoms, exposures, obstruction, and low FVC, were 
estimated using a combination of  the three data sources, and 
is referred to as “pooled data” hereafter. We also calculated 
median (IQR) estimates for CO and PM2.5 exposure.
Figure 2. Funnel plots for lung function estimates in paediatric (blue) and adult (red) populations. Panel A (left): restriction, 
Panel B (right) obstruction.
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Ethics
Liverpool School of  Tropical Medicine provided ethical 
approval for all three studies which we included for 
secondary data analysis (Reference numbers: 12.08, 12.40 
and 14.016). The ALHS and AIR were approved by the 
College of  Medicine Research and Ethics Committee, 
Malawi (References: p.11/12/1308 and P.02/14/1518, 
respectively), and the BHS was approved by the National 
Research and Ethics Committee of  Malawi (Reference: 
12.08). All participants provided informed consent. 
Results
Study selection
Database and grey literature searches on 9 October 2018 and 
updated on 3 June 2019 identified 393 titles for review; 17 
papers met the inclusion criteria (Figure 1)15,16,20,22-35. Funnel 
plots were limited by the small number of  studies but were 
relatively symmetrical (P=0.017 for obstruction and P=0.032 
for restriction, as determined by the Eager test) (Figure 2). 
Quality assessment
Analyses showed that the included studies were of  variable 
quality. Studies that had been specifically designed to assess 
the burden of  non-communicable respiratory disease were 
found to be of  the highest quality (Table 1).  
Study characteristics 
The studies incorporated cohort (n=1)25, case-control 
(n=1)20, and cross-sectional (n=15) study designs (or 
included a cross-sectional description of  non-communicable 
respiratory disease burden nested within a Randomised 
Control Trial or economic evaluation) (Table 2). Five studies 
reported paediatric populations22-26, while 12 reported 
adult populations15,16,20,27-35; one of  the studies included 
a population from 10 to 65 years of  age (Table 2)31. Nine 
studies were from urban settings only (four healthcare or 
clinic-based, three community-based, and the case-control 
and cohort studies were performed in both community and 
health care settings)16,20,22-25,30,35, five were from rural settings 
only (all community-based)15,26,29,31,32,34, and three studies 
incorporated both rural and urban settings (all community-
based)27,28,33.
Symptoms
Thirteen studies assessed self-reported respiratory symptoms 
or diagnoses using questionnaires; of  these, five used BOLD 
questionnaires15,16,20,23,24,26-29,31-34 (Table 3).
In the paediatric population, the most commonly reported 
symptom in the community was wheeze, with a prevalence 
of  12.1%, followed by cough (prevalence 8%)24. In the two 
studies related to the prevalence of  symptoms in hospital 
clinics, cough was more common (41.7% and 37.5%) than 
wheeze (11.2% and 8.1%)23,24. Our meta-analysis estimated 
that the prevalence of  cough symptoms in children was 
29.1±10.6 (P=0.0059, I2=98%, Q-test P<0.0001) (Figure 3). 
Within the adult populations in the community, cough was 
the most commonly reported symptom (range: 3–18.6%), 
followed by shortness of  breath (range: 1.6–13%). Productive 
cough and phlegm production were less commonly reported 
(range: 0.2–9% and 1.4–5.9% respectively). Our meta-
analysis and pooled analysis estimates for prevalence of  
cough symptoms in adults were 13.3±10.6%, P<0.0001, 
Case-control and cohort studies
Selection
(out of 4)
Comparability (out 
of 2)
NCLD assessment (out 
of 3)
Overall score (out 
of 9)
Jary et al., 2017 3 2 2 7
Lelijveld  et al., 2017 3 2 2 7
Descriptive cross-sectional studies
Selection
(out of 3)
NCLD assessment
(out of 2)
Overall score (out 
of 5)
Zverev et al., 2001 1 2 3
Fullerton et al., 2011 2 2 4
To  et al., 2012 2 1 3
Cook  et al., 2013 1 2 3
Jary et al., 2014 1 0 1
Manjomo et al., 2016 2 0 2
Meghji et al., 2016 2 2 4
Mwalukomo et al., 2016 1 2 3
Wang et al., 2016 0 0 0
Banda et al., 2017 2 1 3
Das et al., 2017 1 1 2
Townend et al., 2017 1 2 3
Cohen et al., 2019 1 1 2
Nightingale et al., 2019 2 2 4
Rylance et al., 2019 2 2 4
NCLD: non-communicable lung disease.
Table 1. The risk of bias, as determined by the Newcastle-Ottawa Scale
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I2=93%, Q-test P<0.0001) and 10.7%, respectively (Figure 
3). 
Lung function
Eight of  the nine studies (four paediatric and four adult) 
that performed spirometry reported data that were collected 
in accordance with standards reported by the American 
Thoracic Society (ATS)/European Respiratory Society 
(ERS). However, five different ranges were used and a mix of  
raw values, proportional (%) predicted values and Z-scores 
were used in analysis20,23-27,33-35 (Table 4). 
One study, a community-based cross-sectional study, 
focused on peak expiratory flow rate (PEFR) in stunted 
children, reported that PEFR was reduced in those with 
poor growth20. In paediatric community populations, 6.6–
9.0% of  the population had obstruction while 6.6–7.5% had 
low FVC. In those with sickle cell disease and HIV infection, 
obstructive spirometry was identified in 0 and 18% of  cases 
while low FVC was detected in 25% and 17% of  cases, 
when using local reference ranges (58% and 20% if  using 
international reference ranges), respectively23,24. The cohort 
study that assessed lung function in malnourished children 
reported a reduced FEV1 (forced expiratory volume in 
the first second) and FVC in all study groups, but with no 
significant difference between paediatric survivors of  severe 
acute malnutrition and healthy controls25. The diagnosis of  
asthma in children, based on spirometry and questionnaires, 
was reported in 3.9% of  the community or 12.1% if  wheeze 
was used as the definition; asthma was also reported in 4.2% 
of  children with sickle cell anaemia23,26. None of  the studies 
used the same definition for asthma in the same way.
The range of  obstruction reported in adults where spirometry 
had been completed was 2.3–20% with low FVC varying 
from 2.7% to 52.8%20,27. The use of   different ranges within 
the same population resulted in a prevalence of  obstruction 
of  2.3–4.2%, and low FVC of  9–38.6%, using local and 
NHANES (National Health and Nutrition Examination 
Survey) Caucasian ranges, respectively15,16. The prevalence 
of  asthma in adults ranged from 0% to 12.2% with a 
mixture of  diagnostic types: doctor diagnosis (7.6–12.2%), 
self-reported (4.7–8%) and diagnoses involving spirometry 
(0–4.2%)16,18,25,26,28,30-32. In our meta-analysis, the prevalence 
of  obstruction in adults was 8.3±2.4%, P=0.0007, I2 = 
89%, Q-test P<0.0001), and low FVC 31±7.2%, P<0.0001, 
I2=97%, Q-test P<0.0001 (Figure 2). Pooled analysis 
estimated overall FEV1 of  2.64 L (0.69), FVC of  3.28 L (0.77) 
and FEV1/FVC of  80.5% (8.48). The pooled prevalence of  
obstruction was 8.4% and low FVC was 37.5% (NHANES) 
or 16.3% (using the local range).
Risk factors
The most commonly reported risk factors for non-
communicable respiratory disease were the use of  biomass 
fuel and smoking. Exposure to biomass fuel was assessed 
in a variety of  different ways in different studies. In 
paediatric studies, 14–83% of  the study populations were 
exposed to biomass fuels23,25 (Table 3). In adult studies, 
self-reported exposure to biomass fuel was reported in 
Figure 3. Forest plots and meta-analysis estimates for symptoms (A–D), exposure (E, F) and respiratory outcomes (G, H  ). SOB: shortness 
of breath.
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51–100% of  the study populations29,34. The self-reported 
prevalence of  smoking (“ever smoked”) ranged from 1% 
to 28.2% in the adult population27,30. Previous TB and low 
BMI were considered as possible risk factors in the BOLD 
studies. Meta-analysis and pooled analysis of  associations 
between risk factors and lung function was not possible 
due to the incomplete nature of  reporting across different 
studies15,16,20,34. 
Author (year) Year Rural/Urban Mean 
Age 
(years)
Setting and study design Sample size Assessment methods
Paediatric
Zverev 2001 Urban Children in primary school, children from each class were randomly 
selected
539 Peak expiratory flow 
only. No symptoms 
questionnaires. No 
spirometry
Cook 2013 Urban clinic 11.5 Consecutive recruitment from paediatric Sickle Cell Anaemia Clinic 25 Self-reported respiratory 
symptoms (ISAAC 
questionnaire) and 
spirometry.
Mwalukomo 2016 Urban clinic 11.1 First 3 eligible patients at paediatric HIV clinic per day were 
recruited
160 Self-reported respiratory 
symptoms and clinical 
observation and spirometry
Lelijveld 2017 Urban hospital Cases: consecutive patients admitted with severe acute malnutrition 
in 2006–2007. Sibling controls: closest in age to case. Community 
controls: random direction selected from case home then door-to-
door recruitment (age- & sex-matched).  
320 cases (of 477 alive 1 
year after original discharge); 
217 sibling controls; 184 
community controls
Spirometry 
Rylance 2019 Rural 7.1 Population sampling with control and intervention arm 804 including 476 (260 
intervention and 216 control) 
from CAPS households 
Self-reported respiratory 
symptoms (BOLD 
questionnaire) and 
spirometry
Adult
Fullerton 2011 Rural/urban 39 Cross-sectional survey. Rural: first household semi-randomly 
selected, then snowballing sampling strategy.
Urban: randomly selected from 360 research volunteers, then 
snowballing sampling strategy.
Biased selection toward women
374 Self-reported respiratory 
symptoms and diagnoses 
and spirometry. 
To 2012 Rural/urban Multi-stage cluster design: random 3890 Self-reported respiratory 
symptoms and diagnoses 
and self-reported doctor 
diagnosed.
Jary 2014 Rural 35 Community based survey of women wishing to purchase a 
cookstove – not randomly selected.
51 Self-reported respiratory 
symptoms.
Meghjia 2016 Urban 42 Random sample from enumerated population – age- and sex-
stratified population-representative sample.
1059 (of 1240 eligible) Self-reported respiratory 
symptoms (BOLD 
questionnaire) and 
spirometry. 
Manjomo 2016 Urban All patients registered with NCDs attending a chronic care clinic at a 
primary health care centre.
1135 Diagnosis of asthma at clinic
Wang 2016 Rural Cross sectional survey, from three districts. Sampling method 
unclear. Paediatric adult overlap with participant 10–65 years old. 
5643 individuals from 1199 
households
Self-reported chronic 
respiratory symptoms 
reported as a group
Banda 2017 Rural 36 Population proportional sampling using electronic satellite maps:  
30 villages randomly selected from each cluster (27 health centre 
catchment population), 7 households randomly selected from each 
village.
15795 individuals from 6304 
households with 1728 who 
had health passports checked 
for symptoms
Self-reported respiratory 
symptoms / health passport 
assessment of symptoms.
Das 2017 Rural/peri-urban 37.3 Random sample of households from representative villages. 655 households (382 rural, 
273 peri-urban).
Self-reported respiratory 
symptoms.
Table 2. Summary of the main findings from literature searches (date order)
aFrom the same study population. 
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Author (year) Symptoms (%) Exposures (%)
Cough Wheeze Phlegm SOB Previous TB Ever Smoked Biomass
Paediatric
Zverev at al., 2001
Cook 2013 41.7 11.2 83
Mwalukomo 2016 37.5 8.1 20 46.9
Lelijveld 2017 5 13d 16d
0.6 13d 16d
0.8 15d 14d
Rylance 2019 8 12.1 0.4
Adult
Fullerton 2011 3 6 11 17.5 99
16 9 13 28.2
To 2012 7.8 12.7b
Jary 2014 31 4 4 10 100
Meghji 2016d 7.5 1.4 4.0 3.1 2.9 10.4 85.2
Manjomo 2016 1
Wang et al., 2016 2.0c
Banda 2017 18.6 5.9 5.5 10.1 100
Das 2017 17.3 5.3 10.5 100
Jary 2017 9.3
Townend 2017 5 17 51a
Cohen 2019
Nightingale 2019 11.1 1.6 2.6 1.6 3.2 22.1 99.8
Secondary analysis 
from Malawi (pooled 
data 2019)
10.7 2.2 4.0 3.2 4.1 17.7 92.8
Table 3. Extracted proportions (%) of cases showing symptoms and specific exposures (where reported). Empty cells indicate not 
reported. 
aOpen fire for >20 years. bAfrica region estimate. cChronic symptoms combined. dIndoor tobacco/biofuel use.  SOB: shortness of breath.
Author (year) Group/subgroup Asthma 
(%)
Low FVC 
(%)
Obstruction 
(%)
Reference 
range 
FEV1, L 
Mean (SD)
FVC, L 
Mean (SD)
FEV1/FVC % 
Mean (SD)
Paediatric
Zverev et al 2001 School children
Cook 2013 Clinic 25 0 Local 1.45 (0.54) 1.68 (0.58) 86 (2.09)
58 0 Wang −1.64a −1.49a −0.39a
Mwalukomo 2016 Clinic – HIV infected 20 17.9 GLI −1.31a −0.89a −0.27a
17.2 12.4 Local 92.2b 93.9b 87.9b
Lelijveld 2017 Cases – clinic GLI −0.47 (1.1)a −0.32 (1.0)a −0.21 (0.9)a
Controls – siblings GLI −0.48 (1.0)a −0.38 (1.1)a −0.15 (0.9)a
Controls – population GLI −0.34 (1.1)a −0.15 (1.1)a 0.16 (1.0)a
Rylance 2019 Intervention 4.2 6.6 6.6 GLI −0.41 (0.92)a −0.22 (0.77)a −0.4 (0.91)a
Controls 4.6 9.0 7.5 GLI −0.60 (0.97) −0.44 (0.98)a −0.34 (0.93)a
Population 3.9 6.3 7.1 GLI −0.48 (0.93) −0.30 (0.96) −.038 (0.90)
Table 4. Summary extracted spirometry (FEV1, FVC) or obstruction/low FVC where available. Blank cells indicate data that were 
not reported. 
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Discussion
We conducted a systematic review, secondary data analysis, 
and meta-analysis, of  studies relating to non-communicable 
respiratory disease in Malawi. We identified 17 papers of  
variable quality with  scores on the Newcastle-Ottawa scale 
ranging from 0 to 715,16,20,22-34. Five of  these studies related to 
children while 12 of  the studies involved adult populations. 
In children we found that the main symptom was wheeze, 
with low FVC being reported in 6.3–20% of  the population; 
obstruction was reported in 7.1–17.9% of  the study 
population22-26. In adults, we identified a high burden of  
lung disease, with cough being the most reported symptom. 
In studies that used spirometry as an outcome measure, 
over 40% of  the population showed abnormal spirometry 
results15,16,20,27. Low FVC was the most common abnormal 
spirometry finding, with a pooled population estimate of  
37.5% using NHANES Caucasian reference ranges. We also 
identified a high prevalence of  exposure to biomass fuel 
(50–100%) and a smoking prevalence of  1–21%27,29,30,34.  
Few studies in the published literature have reported chronic 
respiratory symptoms and spirometry data from sub-
Saharan African populations. However, the findings from 
our present systematic review and meta-analysis, which 
focussed on Malawi, are consistent with data arising from 
other sub-Saharan African countries. Data from the ISAAC 
study sites indicated that wheeze occurs in 5–16% of  
children in sub-Saharan Africa, with nearly a half  of  these 
children exhibiting severe symptoms11. On a global basis, 
wheeze has been reported to occur in 0.8–32.6% of  young 
children (aged 6–7 years and 2.4–37.6% in older children 
(age 13–14 years)11. In adults, cough was the most common 
symptom described in studies from sub-Saharan Africa; 
BOLD studies in Nigeria reported a prevalence of  cough 
that was 9.7%36. The prevalence of  obstruction was lower in 
Malawi than that found in both Cape Town (19.1%) and in 
rural Uganda (16.2%), although tobacco smoking was more 
common in both these populations than in Malawi13,37. Two 
recent studies from Uganda found that the prevalence of  
obstruction was 2–6.1% and 2% in a rural setting and 1.5% 
in an urban setting; these figures are more in line with the data 
highlighted in the present review18,17.The high prevalence of  
low FVC that was evident in Malawi was similar to that seen 
in Nigeria and other resource-poor settings. However, there 
is limited a limited body of  literature relating to the possible 
causes of  low FVC in adults residing in sub-Saharan Africa36. 
The major strength of  this study is that it is the first systematic 
review and meta-analysis of  chronic non-communicable 
respiratory disease in Malawi and provides a significant 
enhancement to the growing body of  evidence highlighting 
the high burden of  lung disease seen within Malawi and the 
wider sub-Saharan African region. Our work brings together 
studies of  both paediatric and adult populations from 
diverse settings in Malawi and includes a secondary analysis 
of  data in order to provide new estimates for the pooled 
burden of  disease. The estimates given within this paper 
Adult
Fullerton 2011 Charcoal users 7 2.7 13.6 Knudsen & 
asthma self-
reported
2.78 (0.68) 3.49 (0.87) 79.8 (7.5)
To 2012 Population 4.7
Jary 2014 Women cooking on 
cookstoves
Meghji 2016 Population 4.2 38.6 4.2 NHANES
9 2.3^ Local
Manjomo 2016 Clinic 12.2
Wang et al 2016 Population
Banda 2017 Population reporting 
respiratory symptoms
7.6 0.15 Medical 
Diagnosis 
only
Das 2017 Women cooking on 
biomass
Wood users 8 2.43 (0.67) 3.19 (0.83) 76.5 (9.1)
Jary 2017 Cases – clinic 0 52.8 20 NHANES 2.73 (0.69)
Controls 0 37.5 7.6 NHANES 2.48 (0.68)
Townend 2017 Population 5 NHANES 78 (8)
Cohen 2019^ TB re-treatment patients 
at hospital 
19.4 5.83 NHANES
Nightingale 2019 Population 34.8 8.7 NHANES
Secondary analysis from 
Malawi pooled data 2019
Population 16.3 (Local) 
37.5 
(NHANES)
8.4 NHANES 2.64 (0.69) 3.28 (0.77) 80.5 (8.48)
Table 4 Cont...
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are, however, limited by inconsistent methodologies. The 
studies we reported herein were carried out across a range 
of  populations, from the community setting to subgroups 
within an acute clinic. The paediatric data described herein 
are particularly limited because only one paediatric study 
reported lung function in community settings; the other 
studies related to specific populations, such as children 
with sickle cell disease.  Furthermore, symptoms were not 
reported in a consistent or standardised manner. Cough, 
wheeze, exertional dyspnoea, and the production of  sputum, 
were the most common symptoms reported although there 
was widespread inconsistency in the definitions used for 
these symptoms. All symptoms were self-reported; in studies 
without other diagnostic tools, this inevitably reduced the 
specificity of  diagnosis. Diagnosis of  COPD and asthma 
were made using a combination of  clinical or self-reported 
diagnoses and spirometry. This is likely to explain the wide 
variation seen in categorising the burden of  disease in Malawi. 
All spirometry data were reported in accordance with ATS 
standards. However, studies used different interpretative 
strategies with raw FEV1 and FVC being the most common 
parameters  provided for adult populations and Z-scores 
the most common parameter for the paediatric population. 
This lack of  standardised reporting also created uncertainty 
with regards to the estimation of  disease burden in Malawi 
and resulted in high heterogeneity with regards to the meta-
analysis estimates. As there is no validated reference range 
for spirometry in sub-Saharan African populations, a variety 
of  reference ranges were used in the studies reported here. 
The majority of  paediatric studies used the Global Lung 
Function Initiative (GLI) reference ranges while the majority 
of  adult studies used the NHANES Caucasian reference 
ranges. However, the NHANES Caucasian reference ranges 
are also known to be associated with limitations, including 
the potential overestimation of  the prevalence of  low FVC; 
however, this reference range does allow for comparison with 
other studies, including BOLD studies (the largest, multi-
national study of  spirometry findings thus far). Previous 
studies have also published results that were interpreted with 
local (unvalidated) reference ranges.
Conclusion
In conclusion, we identified a high burden of  chronic 
respiratory symptoms and abnormal spirometry data 
(particularly low FVC) in children and adults in Malawi. 
Estimates for the country-wide burden of  disease were limited 
by the heterogeneity of  the methods used to assess symptoms 
and spirometry. Little is known about the determinants and 
natural history of  non-communicable respiratory disease 
across the life course in Malawi. We strongly recommend 
that non-communicable respiratory disease should be a 
priority for future research in Malawi and that this would 
benefit from the use of  methodologies standardised across 
studies. For example, it would be particularly useful to 
standardise diagnostic definitions and report all spirometry 
data to ATS/ERS standards. A specific consensus on the 
spirometry reference ranges used, or the development of  
locally appropriate specific reference ranges, is also needed. 
The substantial burden of  chronic respiratory symptoms and 
abnormal spirometry data in Malawian children and adults is 
highly evident in our findings. Consequently, it is vital that we 
provide high quality, accessible and affordable care  to this 
population, This has implications for Malawian policy- and 
decision-makers and our efforts to develop universal health 
coverage in Malawi. Although our systematic review and 
meta-analysis deliberately focused on Malawi, our findings 
are of  generalisable relevance to the wider sub-Saharan 
African region. 
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